• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Hepatitis C - Articles and news items

eu hepatitis c european market

MSD’s Hepatitis C drug given green light for EU market

Industry news / 9 August 2016 / MSD

Following successful phase 3 clinical trials, in which MSD’s new Hepatitis C drug, Zepatier, performed well, achieving high virologic cure rates across the study, the European Commission has licensed the drug for sale in the European market, specifically for the treatment of chronic hepatitis C virus (HCV) in adults with genotype 1 and 4 infection…

Hepatitis C

Hepatitis C: commitment to a cure

Blog, Z Homepage promo / 28 July 2016 / Niamh Louise Marriott, Digital Content Producer

To find out more about Hepititis C, European Pharmaceutical Review spoke with Raquel Peck, CEO of the World Hepatitis Alliance and discovered exactly what it is being done to combat this widespread global health issue…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +